← HCA Healthcare, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Accounts receivable $5.8b $6.5b $6.8b $7.4b $7.1b $8.1b $8.9b $10.0b $10.8b $10.9b
Cash and Cash Equivalents, at Carrying Value $646.0m $732.0m $502.0m $621.0m $1.8b $1.5b $908.0m $935.0m $1.9b $1.0b
Cash and cash equivalents $646.0m $732.0m $502.0m $621.0m $1.8b $1.5b $908.0m $935.0m $1.9b $1.0b
Inventory, Net $1.5b $1.6b $1.7b $1.8b $2.0b $2.0b $2.1b $2.0b $1.7b $1.7b
Assets, Current $9.1b $10.0b $10.2b $11.2b $12.3b $13.5b $13.6b $14.9b $16.4b $15.8b
Total current assets $9.1b $10.0b $10.2b $11.2b $12.3b $13.5b $13.6b $14.9b $16.4b $15.8b
Property, Plant and Equipment, Net $16.4b $17.9b $19.8b $22.7b $23.2b $24.1b $25.6b $27.7b $29.4b $31.1b
Goodwill and other intangible assets $6.7b $7.4b $8.0b $8.3b $8.6b $9.5b $9.7b $9.9b $10.1b $10.3b
Operating Lease, Right-of-Use Asset — — — $1.8b $2.0b $2.1b $2.1b $2.2b $2.1b $2.1b
Other Assets, Noncurrent $1.1b $710.0m $690.0m $480.0m $546.0m $598.0m $298.0m $184.0m $230.0m $255.0m
Right-of-use operating lease assets — — — $1.8b $2.0b $2.1b $2.1b $2.2b $2.1b $2.1b
Right-of-use operating lease obligations — — — $1.5b $1.7b $1.8b $1.8b $1.9b $1.9b $1.9b
Additional Financial Items
Accounts Receivable, after Allowance for Credit Loss, Current $5.8b $6.5b $6.8b $7.4b $7.1b $8.1b $8.9b $10.0b $10.8b $10.9b
Accumulated depreciation ($20.7b) ($22.2b) ($23.2b) ($24.5b) ($26.1b) ($27.3b) ($29.2b) ($30.8b) ($33.1b) ($35.1b)
Buildings $13.5b $14.2b $15.7b $17.7b $18.5b $19.2b $20.2b $21.6b $22.7b $23.7b
Construction in progress $1.3b $1.9b $1.8b $1.6b $1.5b $1.4b $1.8b $1.9b $1.9b $2.1b
Equipment $20.6b $22.2b $23.6b $25.8b $27.1b $28.3b $30.0b $32.0b $34.7b $37.0b
Income taxes and other liabilities $1.2b $1.4b $1.2b $1.4b $1.9b $2.1b $1.6b $1.9b $2.0b $2.2b
Investments in and advances to affiliates $206.0m $199.0m $232.0m $249.0m $422.0m $448.0m $823.0m $756.0m $662.0m $633.0m
Investments of insurance subsidiaries $336.0m $418.0m $362.0m $315.0m $388.0m $438.0m $381.0m $477.0m $569.0m $485.0m
Land $1.6b $1.7b $1.9b $2.2b $2.3b $2.5b $2.8b $3.1b $3.3b $3.4b
Other $1.1b $710.0m $690.0m $480.0m $546.0m $598.0m $298.0m $184.0m $230.0m $255.0m
Professional liability risks $1.1b $1.2b $1.3b $1.4b $1.5b $1.5b $1.5b $1.6b $1.5b $1.5b
Retained deficit ($7.0b) ($6.5b) ($4.6b) ($2.4b) $777.0m ($532.0m) ($2.3b) ($1.4b) ($2.1b) ($5.7b)
Stockholders' deficit attributable to HCA Healthcare, Inc. ($7.3b) ($6.8b) ($5.0b) ($2.8b) $572.0m ($933.0m) ($2.8b) ($1.8b) ($2.5b) ($6.0b)
AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax — — — $14.0m $25.0m $12.0m ($30.0m) ($22.0m) ($21.0m) ($11.0m)
Total stockholders' (deficit) equity ($5.6b) ($5.0b) ($2.9b) ($565.0m) $2.9b $1.5b ($73.0m) $1.1b $555.0m ($2.8b)
Assets $33.8b $36.6b $39.2b $45.1b $47.5b $50.7b $52.4b $56.2b $59.5b $60.7b
Total assets $33.8b $36.6b $39.2b $45.1b $47.5b $50.7b $52.4b $56.2b $59.5b $60.7b
LIABILITIES AND EQUITY
Total liabilities and stockholders' (deficit) equity $33.8b $36.6b $39.2b $45.1b $47.5b $50.7b $52.4b $56.2b $59.5b $60.7b
Current liabilities:
Accounts Payable, Current $2.3b $2.6b $2.6b $2.9b $3.5b $4.1b $4.2b $4.2b $4.3b $4.7b
Accrued salaries $1.3b $1.4b $1.6b $1.8b $1.7b $1.9b $1.7b $2.1b $2.3b $2.5b
Long-term Debt, Current Maturities $216.0m $200.0m $788.0m $145.0m $209.0m $237.0m $370.0m $2.4b $4.7b —
Long-term Debt, Excluding Current Maturities $31.2b $32.9b $32.0b $33.6b $30.8b $34.3b $37.7b $37.2b $38.3b $41.6b
Operating Lease, Liability, Current — — — $350.0m $379.0m $392.0m $364.0m $363.0m $343.0m $352.0m
Operating Lease, Liability, Noncurrent — — — $1.5b $1.7b $1.8b $1.8b $1.9b $1.9b $1.9b
Other accrued expenses $2.0b $2.0b $2.6b $2.9b $3.2b $3.3b $3.6b $3.9b $3.9b $4.3b
Liabilities, Current $5.8b $6.2b $7.6b $7.8b $8.7b $9.6b $9.9b $12.7b $15.2b $16.4b
Total current liabilities $5.8b $6.2b $7.6b $7.8b $8.7b $9.6b $9.9b $12.7b $15.2b $16.4b
Long-term debt, less debt issuance costs and discounts of $436 and $369 $31.2b $32.9b $32.0b $33.6b $30.8b $34.3b $37.7b $37.2b $38.3b $41.6b
Short-term borrowings and long-term debt due within one year — — — — — — — — $4.7b $4.9b
Liabilities $39.4b $41.6b $42.1b $45.6b — — — — — —
Stockholders’ equity:
Accumulated Other Comprehensive Income (Loss), Net of Tax ($338.0m) ($278.0m) ($381.0m) ($460.0m) ($502.0m) ($404.0m) ($490.0m) ($425.0m) ($387.0m) ($305.0m)
Accumulated other comprehensive loss ($338.0m) ($278.0m) ($381.0m) ($460.0m) ($502.0m) ($404.0m) ($490.0m) ($425.0m) ($387.0m) ($305.0m)
Additional Paid in Capital, Common Stock — — — — $294.0m $0 — — — —
Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 224,605,100 shares - 2025 and 249,981,400 shares - 2024 4.0m 4.0m 3.0m 3.0m 3.0m 3.0m 3.0m 3.0m 3.0m 2.0m
Retained Earnings (Accumulated Deficit) ($7.0b) ($6.5b) ($4.6b) ($2.4b) $777.0m ($532.0m) ($2.3b) ($1.4b) ($2.1b) ($5.7b)
Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax ($146.0m) ($168.0m) ($148.0m) ($187.0m) ($220.0m) ($132.0m) ($87.0m) ($64.0m) ($13.0m) $5.0m
Stockholders' Equity Attributable to Parent ($7.3b) ($6.8b) ($5.0b) ($2.8b) $572.0m ($933.0m) ($2.8b) ($1.8b) ($2.5b) ($6.0b)
Noncontrolling interests $1.7b $1.8b $2.0b $2.2b $2.3b $2.4b $2.7b $2.8b $3.1b $3.3b
Stockholders' Equity Attributable to Noncontrolling Interest $1.7b $1.8b $2.0b $2.2b $2.3b $2.4b $2.7b $2.8b $3.1b $3.3b
Liabilities and Equity $33.8b $36.6b $39.2b $45.1b $47.5b $50.7b $52.4b $56.2b $59.5b $60.7b

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.